So the authors of that "paper" include:
1) The main person that was pushing for hydroxychloroquine (Peter McCullough):
https://thehill.com/opinion/healthc...researchers-need-access-to-hydroxychloroquine
2) A person who is selling Covid-19 treatments (Thomas Borody):
https://topeliatherapeutics.com/team
3) And people who don't do research into respiratory diseases, other than to tout Ivermectin everywhere they can go.
The 7 studies they used include these three (I'm using the author's own words)
1) "One found no evidence of IVM efficacy"
2) "that compared IVM with two other drug treatment groups but not a placebo group and found no benefit"
3) "The study found no statistically significant symptom improvements with IVM treatment"
They did include data that showed a winter dip of Covid-19 in Peru that corresponded with Ivermectin use. But, they failed to point out a winter dip occurred in many other countries at the same time and those countries did not use Ivermectin for Covid-19. Meaning at best, they show possible correlation at worst they ignored data from almost 200 countries that didn't support their theory.